Risk factors for pneumonia in the elderly

https://doi.org/10.1016/0002-9343(94)90060-4Get rights and content

Abstract

purpose: To investigate the prevalence of certain chronic conditions among the elderly and to estimate the relative risk for pneumonia associated with each condition.

patients and methods: Medical records of all inhabitants aged 60 years or more (4,175 persons) in one township (population 24,716) in Finland were reviewed, seeking 15 chronic conditions. Which patients had pneumonia in the same population was prospectively ascertained over a period of 3 years (185 patients).

results: Hypertension was the most frequent chronic condition (36.4%) in the study population. Other common conditions were heart disease (23.7%, with chronic compensated heart failure in 96.3% of these), other cardiovascular disease (13.1%), and diabetes (13.1%). The prevalence of any other condition was less than 5%. The following conditions were significantly more common among pneumonia patients than among control subjects: heart disease (38.4% versus 23.0%), lung disease (13.0% versus 3.8%), bronchial asthma (11.9% versus 3.1%), immunosuppressive therapy (2.7% versus 0.8%), alcoholism (2.2% versus 0.3%), and institutionalization (8.6% versus 3.9%). By multivariate logistic regression analysis, independent risk factors for pneumonia were alcoholism (relative risk [RR]= 9.0, confidence interval [Cl] = 5.1 to 16.2), bronchial asthma (RR = 4.2, Cl = 3.3 to 5.4), immunosuppressive therapy (RR = 3.1, Cl = 1.9 to 5.1), lung disease (RR = 3.0, Cl = 2.3 to 3.9), heart disease (RR = 1.9, Cl = 1.7 to 2.3), institutionalization (RR = 1.8, Cl = 1.4 to 2.4), and age (70 years or more versus 60 to 69 years; RR = 1.5, Cl = 1.3 to 1.7). One third of the study population and 57% of the pneumonia patients had one or more of these risk factors. Diabetes, chronic pyelonephritis, and malignancies of sites other than the lungs were not associated with increased risk for pneumonia.

conclusion: We found which elderly persons have an increased risk for pneumonia. Although the highest relative risk was associated with alcoholism, that condition was rare in this elderly population. Chronic obstructive lung diseases were more common and were also associated with a high relative risk. Heart disease had the highest public health impact because it was very common among the elderly and increased the risk of contracting pneumonia almost twofold; it also increased the risk of pneumonia-related death. These population-based data confirm and extend previous findings derived from selected patient groups and are useful for designing cost-effective pneumonia prevention programs.

References (39)

  • GJ Dorff et al.

    Etiologies and characteristic features of pneumonias in a municipal hospital

    Am J Med Sci.

    (1973)
  • RJ White et al.

    Causes of pneumonia presenting to a district general hospital

    Thorax.

    (1981)
  • MA Mufson et al.

    Pneumococcal disease in a medium-sized community in the United States

    JAMA

    (1982)
  • JT Mcfarlane et al.

    Hospital study of adult community-acquired pneumonia

    Lancet

    (1982)
  • E Berntsson et al.

    Etiology of community-acquired pneumonia in patients requiring hospitalization

    Eur J Clin Microbiol Infect Dis.

    (1985)
  • TJ Marrie et al.

    Community-acquired pneumonia requiring hospitalization: 5-year prospective study

    Rev Infect Dis.

    (1989)
  • E Berntsson et al.

    Etiology of community-acquired pneumonia in outpatients

    Eur J Clin Microbiol Infect Dis.

    (1986)
  • British Thoracic Society

    Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiology, mortality, prognostic factors and outcome

    Q J Med.

    (1987)
  • V Ausina et al.

    Prospective study on the etiology of community-acquired pneumonia in childern and adults in Spain

    Eur J Clin Microbiol Infect Dis.

    (1988)
  • Cited by (310)

    View all citing articles on Scopus

    This study was supported by the Paulo Foundation, the Päivikki and Sakari Sohlberg Foundation, the Tampere Tuberculosis Foundation, the Väinö and Laina Kivi Foundation, and the Orion Corporation Research Foundation.

    View full text